Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Masuzyo Chirwa Chobe"'
Autor:
Adriace Chauwa, Samuel Bosomprah, Natasha Makabilo Laban, Bernard Phiri, Mwelwa Chibuye, Obvious Nchimunya Chilyabanyama, Sody Munsaka, Michelo Simuyandi, Innocent Mwape, Cynthia Mubanga, Masuzyo Chirwa Chobe, Caroline Chisenga, Roma Chilengi
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1303 (2023)
Live-attenuated, oral rotavirus vaccines have significantly reduced rotavirus-associated diarrhoea morbidity and infant mortality. However, vaccine immunogenicity is diminished in low-income countries. We investigated whether maternal and infant intr
Externí odkaz:
https://doaj.org/article/93acf773ead44f728f3ac29892fe471c
Autor:
Evelyn Muleba Kunda-Ng'andu, Michelo Simuyandi, Melissa Kapulu, Masuzyo Chirwa-Chobe, Hope Mwanyungwi-Chinganya, Stanley Mwale, Roma Chilengi, Anjali Sharma
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Human infection studies (HIS) have generally been used as a tool in the pathway for vaccine development in high income settings. Over the last decade, this model has been implemented in LMICs with the aim of accelerating development of next generatio
Externí odkaz:
https://doaj.org/article/0cd97a6c799c4199b3b11adfb5f68c83
Autor:
Evelyn Muleba Kunda-Ng'andu, Michelo Simuyandi, Melissa Kapulu, Masuzyo Chirwa-Chobe, Hope Mwanyungwi-Chinganya, Stanley Mwale, Roma Chilengi, Anjali Sharma
Publikováno v:
Wellcome Open Research, Vol 6 (2021)
Human infection studies (HIS) have generally been used as a tool in the pathway for vaccine development in high income settings. Over the last decade, this model has been implemented in LMICs with the aim of accelerating development of next generatio
Externí odkaz:
https://doaj.org/article/524499df24b3461282bfdad5ca2a6e56
Autor:
Evelyn Muleba Kunda-Ngándu, Masuzyo Chirwa-Chobe, Chanda Mwamba, Jenala Chipungu, Esnart Ng'andu, Hope Mwanyungwi Chinganya, Michelo Simuyandi, Roma Chilengi, Anjali Sharma
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254278 (2021)
Human Infection Studies (HIC) involve intentional infection of volunteers with a challenge agent or pathogen with the aim of understanding and developing vaccines as well as understanding the disease pathophysiology in a well-controlled environment.
Externí odkaz:
https://doaj.org/article/8ed7c5255e5d4bb78d9fd5986be689ce
Autor:
Natasha Makabilo Laban, Samuel Bosomprah, Michelo Simuyandi, Mwelwa Chibuye, Adriace Chauwa, Masuzyo Chirwa-Chobe, Nsofwa Sukwa, Chikumbutso Chipeta, Rachel Velu, Katanekwa Njekwa, Cynthia Mubanga, Innocent Mwape, Martin Rhys Goodier, Roma Chilengi
Publikováno v:
Vaccines, 11(2):346. Multidisciplinary Digital Publishing Institute
Vaccines
Volume 11
Issue 2
Pages: 346
Vaccines
Volume 11
Issue 2
Pages: 346
Oral rotavirus vaccines show diminished immunogenicity in low-resource settings where rotavirus burden is highest. This study assessed the safety and immune boosting effect of a third dose of oral ROTARIX® (GlaxoSmithKline) vaccine administered at 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc88577e5c8f1ee8f882a7763b8a226
https://pure.amc.nl/en/publications/evaluation-of-rotarix-booster-dose-vaccination-at-9-months-for-safety-and-enhanced-antirotavirus-immunity-in-zambian-children(7ca844a7-c23a-4305-b993-aabf73791968).html
https://pure.amc.nl/en/publications/evaluation-of-rotarix-booster-dose-vaccination-at-9-months-for-safety-and-enhanced-antirotavirus-immunity-in-zambian-children(7ca844a7-c23a-4305-b993-aabf73791968).html
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia
Autor:
Katayi Mwila-Kazimbaya, Natasha Makabilo Laban, Elena Banda, Chileshe Mabula-Bwalya, Anita S. Iyer, David A. Sack, Peter Ibukun Oluwa Alabi, Mohammad Ali, Patrick Shea, Kelsey N. Murt, Masuzyo Chirwa-Chobe, John Mwaba, Geoffrey Kwenda, Roma Chilengi, Jason B. Harris, Amanda K. Debes, Michelo Simuyandi, Samuel Bosomprah, Malathi Ram, Paul Scalzo, Caroline C. Chisenga, Harriet Ng'ombe, Shaoming Xiao
Publikováno v:
Vaccine. 39:4516-4523
Two-dose killed oral cholera vaccines (OCV) are currently being used widely to control cholera. The standard dose-interval for OCV is 2 weeks; however, during emergency use of the vaccine, it may be more appropriate to use the available doses to quic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bf8d2d4e09858bdcb95892d614d9ac4
https://doi.org/10.1016/j.vaccine.2021.06.034
https://doi.org/10.1016/j.vaccine.2021.06.034
Autor:
Chanda Mwamba, Evelyn Muleba Kunda-Ng'andu, Masuzyo Chirwa-Chobe, Esnart Ng'andu, Anjali Sharma, Roma Chilengi, Jenala Chipungu, Michelo Simuyandi, Hope Mwanyungwi Chinganya
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 7, p e0254278 (2021)
PLoS ONE, Vol 16, Iss 7, p e0254278 (2021)
Background: Human Infection Studies (HIS) involve intentional infection of volunteers with a challenge agent or pathogen in controlled conditions with the aim of developing vaccines. Though sub-Saharan Africa carries the highest burden of vaccine-pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd7e4a0ca6158902731ab33f0f25f0d
https://pubmed.ncbi.nlm.nih.gov/34242320
https://pubmed.ncbi.nlm.nih.gov/34242320
Autor:
Anjali Sharma, Stanley Mwale, Michelo Simuyandi, Hope Mwanyungwi-Chinganya, Roma Chilengi, Masuzyo Chirwa-Chobe, Melissa C. Kapulu, Evelyn Muleba Kunda-Ng'andu
Publikováno v:
Wellcome Open Research
Human infection studies (HIS) have generally been used as a tool in the pathway for vaccine development in high income settings. Over the last decade, this model has been implemented in LMICs with the aim of accelerating development of next generatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6866cbbe53ea85bde5fbe73dceba07
https://doi.org/10.12688/wellcomeopenres.16432.1
https://doi.org/10.12688/wellcomeopenres.16432.1